This in silico study revealed that the six known compounds have good inhibitory action to T2DM targets, namely, RBP4 and AKR1B1, which contribute in improving insulin sensitivity and prevent diabetes complication, respectively. This evidence concerns the gene AKR1B1 and type 2 diabetes mellitus.